About Herve Hoppenot

Herve Hoppenot is President and CEO of Incyte, a global biopharmaceutical company headquartered in Wilmington, Delaware.

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Since 2002 Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders.

Incyte’s unique expertise in medicinal chemistry and biology have enabled us to create a diversified pipeline of clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing portfolio of medicines across Oncology and Inflammation & Autoimmunity.

Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

Incyte is loved because...

This pharma company offers benefits like 100 percent health insurance coverage for employees (95 percent for dependents) and, since 2017, parental leave for all situations.

Herve Hoppenot Serves as a Model of Incyte's Values because…

Prioritizing the company’s commitment to sound and precise science, passionately encouraging exploration of uncharted territories and putting full trust in the Incyte team.